European Archives - Page 210 of 1213 - European Medical Journal

Phase 2 Trial Results: TAK-071 Enhances Cognition in Parkinson’s Disease

TAK-071 enhances cognition in Parkinson’s disease but doesn’t reduce gait variability, phase 2 trial results reveal.

New Model Predicts Gastrointestinal Lesions in Eosinophilic Granulomatosis with Polyangiitis

A new study develops a model to predict gastrointestinal lesions in eosinophilic granulomatosis, highlighting eosinophils as a critical risk factor.

Cardiovascular Disease Increases Risk of Advanced Breast Cancer

Advanced breast cancer patients are likelier to have pre-existing cardiovascular disease, urging integrated screening strategies for early detection.

Longer Rescreening Intervals After Negative Colonoscopy for Low-Risk Individuals

A study suggests extending colonoscopy rescreening beyond 10 years for low-risk individuals, based on long-term colorectal cancer outcomes.

Increased ME/CFS Risk in Adults Post-COVID-19

The ongoing RECOVER-Adult study reveals that myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) develops significantly more frequently following SARS-CoV-2 infection.

Time-Restricted Eating with Exercise Reduces Fat Mass

A new meta-analysis has provided further insight into the effects of time-restricted eating combined with exercise on body composition.

How Comorbid Conditions Influence Alopecia Areata Progression

A comprehensive study of 2,657 patients assessed the relationship between chronic inflammatory disease comorbidities and alopecia areata characteristics.

Donor Heart Size Matching via Echocardiography Improves Transplant Outcomes

Echocardiographic donor heart size matching improves heart transplant outcomes, outperforming traditional methods, especially for obese recipients.

Adaptive Radiotherapy: A Safer Alternative to Cystectomy

In the RAIDER trial, 82% of patients received dose-escalated radiotherapy and experienced minimal late toxicity.

Blood Marker Predicts 5-Year Mortality in Patients With COPD

A high blood NMLR is linked to increased 5-year mortality in COPD patients, highlighting its role as a key prognostic tool.